ARTICLE

FindCenter AddIcon

Repeated Ketamine Infusions Reduce PTSD Symptom Severity

By ScienceDaily — 2021

Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a new study.

Read on www.sciencedaily.com

FindCenter Post-Image

Introducing Ayahuasca

Amazonian healing traditions collide with Western medical sensibilities.

Article
Zoe Jahn, Monnica T. Williams
2019
FindCenter AddIcon
FindCenter Post-Image

Could the Embrace of Psychedelics Lead to a Mental-Health Revolution?

The last time I was on ketamine, I was hooked up to an IV following surgery. This time, the drug—in general medical use as an anesthetic since 1970—arrived on my doorstep courtesy of Mindbloom, a new telemedicine company specializing in ketamine-based psychedelic therapy.

Article
Maya Singer
2021
FindCenter AddIcon
FindCenter Post-Image

Psychedelics Could Trigger a ‘Paradigm Shift’ in Mental Health Care

A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.

Article
Carolyn Gregoire
2015
FindCenter AddIcon
FindCenter Post-Image

Psychedelic Drugs Can Help Treat PTSD Caused by Racism, Discrimination: Researchers

Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.

Article
Avis Favaro, Elizabeth St. Philip, Solarina Ho
2021
FindCenter AddIcon
FindCenter Post-Image

The Return of Psychedelics to Counseling: Are We Ready?

Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.

Article
Benjamin Hearn
2020
FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Article
Maureen Meehan
2017
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Sessions: Psychedelics Could Help People with Addiction and Anxiety

Study participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less.

Article
Anderson Cooper
2019
FindCenter AddIcon
FindCenter Post-Image

LSD & PTSD: The Case for Using LSD to Relieve PTSD

So, can lysergic acid diethylamide help alleviate the suffering associated with PTSD?

Article
Samuel Douglas
2021
FindCenter AddIcon
FindCenter Post-Image

LSD May Cure Some Addicts

Psychedelic drugs are making a quiet comeback, as a smattering of recent studies have demonstrated their medicinal potential. The latest finding suggests it is time to revisit LSD as a treatment for addiction.

Article
Ian Chant
2012
FindCenter AddIcon
FindCenter Post-Image

Scientists Show How LSD Blows Open the Doors of Perception

The drug lowers brain barriers, allowing distant regions to talk and thoughts to flow more freely.

Article
Ben Turner
2021
FindCenter AddIcon

EXPLORE TOPIC

Ketamine